Abstract:Aims and objectives: The purpose of this study was to compare efficacy and side effects between oral propranolol combined with and without intralesional injection of lauromacrogol for infantile hemangioma (IH). Material and methods: This was a single center randomized controlled prospective study, all participants were firstly diagnosed with IH between August 2022 and January 2023 in our hospital and without any treatment before. Patients were randomized into two groups. PRO group: oral propranolol (2 mg/kg/day) continued for 6 months; PRO + LAU group: oral propranolol (2 mg/kg/day) for 6 months and intralesional injection of lauromacrogol for 2–4 times within 6 months. The dimensions, color, consistency, photographic documentation were well recorded based on Visual Analogue Scale (VAS) before and after starting treatment. According to the treatment response after 6 months, the results were classified into four levels: Grade 1, complete resolution achieved; Grade 2, with ≥50% reduction in size of IH; Grade 3, with <50% reduction in size of IH; Grade 4, no response or worsening of IH. Results: A total of 67 patients were involved in the study (17 boys, 50 girls; mean age, 3.6 months, range, 1.1–7.2 months) and randomized to receive oral propranolol combined with or without intralesional injection of lauromacrogol (29 in PRO group, 38 in PRO + LAU group). All patients completed treatment. Eleven patients (37.9%) in PRO group were in Grade 1, 14 patients (48.3%) in Grade 2, 4 patients (13.8%) in Grade 3, compared with these in PRO + LAU group, 11 patients (28.9%) in Grade 1, 24 patients (63.2%) in Grade 2, and 3 patients (7.9%) in Grade 3. No patient was in Grade 4, and no severe side effects were observed in both group. In PRO group, it takes an average of 17.1 ± 5.4 weeks from the start of treatment to cure, and in PRO + LAU group, the average time is 13.7 ± 4.9 weeks. Conclusion: Oral propranolol with intralesional injection of lauromacrogol was a safety treatment strategy for IH. But it was not superior to oral propranolol in final cure rates ( P = 0.45), moreover, it cannot certainly offer the benefits of shortening the duration of oral drug treatment ( P = 0.24).

Analysis of the Effectiveness of Different Injection Methods of Ultrasonic Guidance in the Treatment of Hepatic Hemangioma

Clinical application of ultrasound-guided percutaneous lauromacrogol sclerotherapy for symptomatic uterine fibroids

Clinical Assessment of Sonographically Guided Microwave Coagulation Therapy in Patients with Liver Carcinoma

Ultrasound-guided Lauromacrogol Injection Therapy for Thyroid Cystic Lesions: Analysis of Its Efficacy and Safety

Lauromacrogol foam injection under ultrasonic guidance for pediatric lip venous malformations

Endoscopic injection of lauromacrogol foam sclerotherapy for rectal cavernous hemangioma: A case report

Percutaneous microwave ablation versus sclerotherapy for large hepatic hemangioma: a multi-center cohort study

Endoscopic ultrasound-guided lauromacrogol injection for treatment of colorectal cavernous hemangioma: Two case reports

DSA-guided foam sclerotherapy of lauromacrogol in treatment of lower extremity varicose veins

Outcomes Of Ultrasound-Guided Percutaneous Microwave Ablation Versus Surgical Resection For Symptomatic Large Hepatic Hemangiomas

Efficacy Assessment and Analysis of Related Factors of Ultrasound‐Guided Percutaneous Lauromacrogol Injection for Cystic Thyroid Nodules

Ultrasound-guided Hot Lipiodol With90 Yintratumor Intra-Tumor Injectionon on Liver Cancer

Efficacy, Safety and Feasibility of Ultrasound-Guided Percutaneous Microwave Ablation for Large Hepatic Hemangioma.

1282: Injection Therapy of Hepatic or Splenic Hemorrhagic Trauma Under Contrast-Enhanced Ultrasound Guidance

Efficacy of Bleomycin-Lauromacrogol Foam in Pediatric Macrocystic Lymphatic Malformations With and Without Intracapsular Hemorrhage

Standardized Treatment and Problems Worthy of Attention for Hemangioma of Liver

Comparison of efficacy and safety between oral propranolol combined with and without intralesional injection of lauromacrogol for infantile hemangioma

Ultrasound-guided Lauromacrogol injection sclerotherapy in spermatic cord hydrocele

Feasibility, Safety, and Efficacy of Ultrasound-Guided Percutaneous Microwave Ablation for Giant Hepatic Hemangioma

The treatment of hemangioma and vascular malformation:a report of 863 cases

[The New Technology of Enhanced Radiofrequency Ablation is Safe and Effective for Treating Giant Hepatic Hemangioma].